Table 5.
Post Hoc Analysis Comparing Onset Interval Between (a) Vaccines and (b) Doses
| Retinal Venous Occlusion | BNT162b2 | mRNA-1273 | Ad26.Cov2.s |
|---|---|---|---|
| BNT162b2 | 1 | ||
| mRNA-1273 | 0.5057 | ||
| Ad26.Cov2.s | < 0.0001 | < 0.0001 | 1 |
| Retinal arterial occlusion | |||
| BNT162b2 | 1 | ||
| mRNA-1273 | 0.6976 | 1 | |
| Ad26.Cov2.s | 0.9995 | 0.9714 | 1 |
| Retinal Venous Occlusion | First Dose | Second Dose | Third Dose | Fourth Dose |
|---|---|---|---|---|
| First dose | 1 | |||
| Second dose | 0.2056 | 1 | ||
| Third dose | 0.9013 | 0.1197 | 1 | |
| Fourth dose | 0.9230 | 0.7816 | 0.9706 | 1 |
| Retinal arterial occlusion | ||||
| First dose | 1 | |||
| Second dose | 0.0918 | 1 | ||
| Third dose | 0.4604 | 1 | 1 | |
| Fourth dose | 0.9884 | 0.8971 | 0.9031 | 1 |